Affordable Access

Publisher Website

A double-blind, placebo-controlled study of antidepressant augementation with mirtazapine

Authors
Journal
Biological Psychiatry
0006-3223
Publisher
Elsevier
Publication Date
Volume
51
Issue
2
Identifiers
DOI: 10.1016/s0006-3223(01)01262-8
Keywords
  • Mirtazapine
  • Refractory Depression
  • Treatment
  • Augmentation
  • Antidepressants
  • Resistant
Disciplines
  • Medicine

Abstract

Abstract Background: A previous pilot study of open-label mirtazapine augmentation conducted by the authors in 20 depressed patients yielded a 55% response rate at week 4. A double-blind controlled trial was undertaken to further elucidate the efficacy of this intervention. Methods: 26 adult outpatients with persistent major depression despite adequate antidepressant monotherapy were randomized to receive 4 weeks of mirtazapine or placebo augmentation. Mirtazapine was begun at 15 mg at bedtime, with possible titration to 30 mg at bedtime per physician’s discretion after week 1. Results: Categorical positive response rate at end point was 64% for active drug and 20% for placebo. Remission rates were 45.4% and 13.3% for active drug and placebo groups, respectively, Mirtazapine demonstrated statistically significant superiority to placebo on most major outcome measures, and was associated with improvement in overall functioning and quality of life. There were no significant group differences with regard to emergent side effects, weight change, or serum concentrations of primary antidepressants. Conclusions: Mirtazapine appears safe and effective for short-term antidepressant augmentation.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

A double-blind, placebo-controlled study of antide...

on Biological Psychiatry Jan 15, 2002

Mirtazapine in essential tremor: a double-blind, p...

on Movement disorders : official... May 2003

Mirtazapine in generalized social anxiety disorder...

on International clinical psychop... September 2010

Mirtazapine treatment of social phobia in women: a...

on Journal of Clinical Psychophar... December 2005
More articles like this..